Feline Bacterial Respiratory Infections: Etiology and Management

Introduction

Feline bacterial respiratory infections represent a significant component of upper and lower respiratory tract disease in domestic cats. While viral pathogens such as feline herpesvirus 1 (FHV-1) and feline calicivirus (FCV) are frequently inciting agents, primary and secondary bacterial infections contribute substantially to morbidity, clinical severity, and chronicity. The term cat bacterial respiratory infection encompasses a spectrum of diseases ranging from acute rhinosinusitis to bronchopneumonia. Understanding the etiology, pathogenesis, and evidence based management of these infections is essential for veterinary clinicians. This article provides a detailed review of the primary bacterial pathogens involved, their epidemiology, clinical presentation, diagnostic approaches, therapeutic strategies, and control measures.

Etiology

The bacterial agents most commonly implicated in feline respiratory infections include Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma felis. Other opportunistic bacteria such as Pasteurella multocida, Streptococcus spp., Escherichia coli, and Staphylococcus spp. are frequently isolated from secondary infections, particularly in cases of chronic rhinosinusitis or pneumonia.

Bordetella bronchiseptica

Bordetella bronchiseptica is a Gram negative, aerobic coccobacillus that colonizes the ciliated respiratory epithelium. It is a primary pathogen in cats, particularly in high density housing environments such as shelters and catteries. The bacterium produces several virulence factors including adhesins (filamentous hemagglutinin, fimbriae) and toxins (tracheal cytotoxin, dermonecrotic toxin) that impair mucociliary clearance and induce ciliostasis and epithelial necrosis. Transmission occurs via direct contact with infected respiratory secretions or aerosolized droplets. Fomite transmission is also possible. The organism can survive for several days in the environment under appropriate conditions.

Chlamydia felis

Chlamydia felis is an obligate intracellular Gram negative bacterium that primarily causes conjunctivitis in cats. It is a common cause of feline upper respiratory tract infection, often presenting with ocular signs. The organism infects epithelial cells of the conjunctiva and respiratory mucosa, replicating within cytoplasmic inclusions. Transmission is direct via ocular and nasal secretions. C. felis is less commonly associated with lower respiratory tract disease but can contribute to pneumonitis in kittens.

Mycoplasma felis

Mycoplasma felis is a cell wall deficient bacterium that colonizes the mucosal surfaces of the upper respiratory tract and conjunctiva. It is frequently isolated from cats with conjunctivitis and upper respiratory signs. M. felis adheres to epithelial cells via specialized adhesins and can induce ciliostasis and inflammation. It is often found as a co pathogen with other respiratory agents.

Opportunistic and Secondary Bacteria

In cases of chronic rhinosinusitis, viral damage, or immunosuppression, a variety of commensal and environmental bacteria can proliferate. Pasteurella multocida is a common isolate from the feline oral cavity and upper respiratory tract and can cause pneumonia following aspiration or viral compromise. Streptococcus spp., Escherichia coli, and Staphylococcus spp. are frequently cultured from cases of bacterial bronchopneumonia. Anaerobic bacteria such as Fusobacterium spp. and Bacteroides spp. are often involved in chronic sinusitis and abscessation.

Epidemiology

The prevalence of bacterial respiratory pathogens in cats varies by population. In shelter and cattery settings, B. bronchiseptica seroprevalence can exceed 50% in some studies. C. felis is more common in multicat households and breeding colonies. M. felis is ubiquitous and can be isolated from healthy carriers. Risk factors for bacterial respiratory infection include young age, stress, overcrowding, poor ventilation, concurrent viral infection, and immunosuppressive conditions such as feline leukemia virus (FeLV) or feline immunodeficiency virus (FIV) infection.

Clinical Signs

Clinical signs of cat bacterial respiratory infection depend on the pathogen involved and the anatomic site affected.

Upper Respiratory Tract Infection

Signs include serous to mucopurulent nasal discharge, sneezing, conjunctivitis, ocular discharge, and submandibular lymphadenopathy. Cats with B. bronchiseptica infection often present with a prominent cough, which is less common in viral infections. C. felis infection is characterized by severe conjunctivitis, chemosis, and ocular discharge, often with mild respiratory signs. M. felis infection typically causes conjunctivitis and mild sneezing.

Lower Respiratory Tract Infection

Bacterial pneumonia presents with cough, dyspnea, tachypnea, fever, lethargy, and anorexia. Auscultation may reveal crackles, wheezes, or dull lung sounds. Pleural effusion can occur in severe cases.

Pathology

Bordetella bronchiseptica

Gross pathology reveals hyperemia and edema of the tracheal and bronchial mucosa with excessive mucoid exudate. Microscopically, there is ciliostasis, epithelial necrosis, and neutrophilic infiltration of the lamina propria. In severe cases, bronchopneumonia with alveolar filling by neutrophils and macrophages is observed.

Chlamydia felis

Conjunctival histopathology shows epithelial hyperplasia, intra cytoplasmic inclusions, and lymphoplasmacytic infiltration. In the lung, mild interstitial pneumonitis with mononuclear cell infiltration may be present.

Mycoplasma felis

Infection induces ciliostasis and epithelial cell damage with a mild neutrophilic and lymphocytic inflammatory response. In the conjunctiva, there is follicular hyperplasia.

Diagnostics

Accurate diagnosis of feline bacterial respiratory infections requires a combination of clinical assessment, cytology, culture, and molecular testing.

Sample Collection

Nasal swabs, conjunctival swabs, oropharyngeal swabs, and transtracheal washes are appropriate samples depending on the clinical presentation. For lower respiratory disease, bronchoalveolar lavage (BAL) is preferred.

Cytology

Cytological examination of swabs or lavage fluid can reveal neutrophilic inflammation with intracellular bacteria. B. bronchiseptica appears as small Gram negative coccobacilli. C. felis inclusions are visible on Giemsa or modified Gimenez stained preparations. M. felis appears as small basophilic coccobacilli without a cell wall.

Culture and Antimicrobial Susceptibility

Aerobic bacterial culture on blood agar and MacConkey agar is standard for B. bronchiseptica and opportunistic bacteria. C. felis requires cell culture or specialized media. M. felis requires specific mycoplasma media. Antimicrobial susceptability testing (AST) should be performed on significant isolates to guide therapy.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays are highly sensitive and specific for detecting B. bronchiseptica, C. felis, and M. felis. Multiplex PCR panels that include viral and bacterial targets are commercially available and allow simultaneous detection of multiple pathogens. Quantitative PCR (qPCR) can provide information on bacterial load.

Serology

Serological testing for C. felis and B. bronchiseptica is available but has limited utility in individual diagnosis due to high seroprevalence in some populations.

Treatment

Antimicrobial therapy should be guided by AST results whenever possible. Empirical therapy is often initiated while awaiting culture results.

Antimicrobial Agents

Doxycycline is the drug of choice for B. bronchiseptica, C. felis, and M. felis due to its excellent tissue penetration and intracellular activity. Fluoroquinolones are effective but should be used judiciously to minimize resistance development. Azithromycin is an alternative, particularly in kittens.

Supportive Care

Supportive care is critical. This includes ensuring adequate hydration, nutritional support, and environmental enrichment. Nebulization with saline can help loosen respiratory secretions. Mucolytics such as N acetylcysteine may be used in severe cases. In cases of nasal congestion, steam therapy can provide relief.

Duration of Therapy

Treatment duration is typically 7 to 14 days for uncomplicated upper respiratory infections. Chronic rhinosinusitis may require 4 to 6 weeks of therapy. Clinical improvement should be monitored, and repeat culture or PCR may be indicated in non responsive cases.

Control and Prevention

Biosecurity

In multicat environments, strict biosecurity measures are essential. This includes isolation of affected cats, disinfection of surfaces with agents effective against bacteria (e.g., accelerated hydrogen peroxide, bleach solutions), and hand hygiene. B. bronchiseptica can survive in the environment, so thorough cleaning is necessary.

Vaccination

Vaccines are available for B. bronchiseptica and C. felis. The B. bronchiseptica vaccine is an intranasal modified live vaccine that provides local immunity. The C. felis vaccine is an injectable inactivated vaccine. Vaccination is recommended for cats in high risk environments such as shelters and catteries. Vaccination does not prevent infection but reduces clinical severity and shedding.

Management of Concurrent Viral Infection

Control of FHV-1 and FCV through vaccination and stress reduction is important, as viral infection predisposes to secondary bacterial infection. Cats with chronic viral carriage may benefit from L lysine supplementation (for FHV-1) or interferon omega therapy, though evidence for efficacy is variable.

Decision Tree for Diagnosis and Management

flowchart TD
    A[Cat with respiratory signs], > B{Clinical examination}
    B, > C[Nasal discharge, sneezing, conjunctivitis]
    B, > D[Cough, dyspnea, fever]
    C, > E[Collect conjunctival/nasal swabs]
    D, > F[Collect BAL or transtracheal wash]
    E, > G[Cytology + PCR + Culture/AST]
    F, > G
    G, > H{Pathogen identified?}
    H, >|B. bronchiseptica| I[Doxycycline or fluoroquinolone]
    H, >|C. felis| J[Doxycycline]
    H, >|M. felis| K[Doxycycline]
    H, >|Opportunistic bacteria| L[AST guided therapy]
    H, >|No pathogen| M[Supportive care, consider viral testing]
    I, > N[Reassess in 7-14 days]
    J, > N
    K, > N
    L, > N
    N, > O{Clinical improvement?}
    O, >|Yes| P[Complete course]
    O, >|No| Q[Repeat diagnostics, consider imaging]

Conclusion

Feline bacterial respiratory infections are a common and clinically important group of diseases. Accurate diagnosis using cytology, culture, and molecular methods is essential for targeted antimicrobial therapy. Doxycycline remains a cornerstone of treatment for the primary bacterial pathogens. Prevention through biosecurity, vaccination, and management of predisposing viral infections is critical in high risk populations. Antimicrobial stewardship, guided by AST, is necessary to preserve the efficacy of available drugs.

References

1. Sykes JE. Feline upper respiratory tract infections. In: Sykes JE, ed. Canine and Feline Infectious Diseases. Elsevier; 2014: 195-210.
2. Lappin MR. Feline upper respiratory tract infections. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier; 2012: 935-946.
3. Gaskell RM, Dawson S. Feline respiratory disease. In: Chandler EA, Gaskell CJ, Gaskell RM, eds. Feline Medicine and Therapeutics. 3rd ed. Blackwell; 2004: 435-452.
4. Hartmann K, Levy JK. Feline infectious diseases. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 7th ed. Elsevier; 2010: 935-946.
5. Foley JE, Rand C, Bannasch MJ, et al. Molecular epidemiology of feline bordetellosis in two animal shelters in California, USA. Prev Vet Med. 2002;54(2):141-156.
6. Helps CR, Lait P, Damhuis A, et al. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Vet Rec. 2005;156(21):669-673.
7. Bannasch MJ, Foley JE. Epidemiologic evaluation of multiple respiratory pathogens in cats in animal shelters. J Feline Med Surg. 2005;7(2):109-119.
8. Johnson LR, Foley JE, De Cock HEV, et al. Assessment of infectious organisms associated with chronic rhinosinusitis in cats. J Am Vet Med Assoc. 2005;227(4):579-585.
9. Veir JK, Lappin MR, Foley JE. Feline respiratory tract infections. In: Bonagura JD, Twedt DC, eds. Kirk's Current Veterinary Therapy XV. Elsevier; 2014: 1271-1276.
10. Sparkes AH, Caney SMA, Sturgess CP, et al. The clinical efficacy of doxycycline in the treatment of feline upper respiratory tract infections. J Feline Med Surg. 1999;1(2):87-93.
11. Hartmann AD, Helps CR, Lappin MR, et al. Efficacy of pradofloxacin in the treatment of feline upper respiratory tract infections. J Feline Med Surg. 2008;10(4):358-365.
12. Litster A, Wu CC, Leutenegger CM. Detection of feline upper respiratory tract pathogens using a commercially available real-time PCR test. Vet J. 2015;206(2):149-153.
13. Schulz BS, Wolf G, Hartmann K. Bacteriological and antibiotic sensitivity test results in 271 cats with respiratory tract infections. Vet Rec. 2006;158(8):269-273.
14. Dowers KL, Hawley JR, Brewer MM, et al. Association of Bartonella species, feline herpesvirus 1, and feline calicivirus with feline upper respiratory tract infections. J Feline Med Surg. 2010;12(4):314-319.
15. Sykes JE, Anderson GA, Studdert VP, et al. Prevalence of feline Chlamydia psittaci and feline herpesvirus 1 in cats with upper respiratory tract disease. J Vet Intern Med. 1999;13(3):153-162.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.